F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine

Neither remdesivir nor HCQ affect viral clearance in hospitalized patients with COVID-19

FDA to announce new warning for J&J vaccine after cases of rare autoimmune disorder

Mathematicians develop ground-breaking modeling toolkit to predict local COVID-19 impact